新的代理人正在到来,所以是抵抗
J Myles Keck1, Alina Viteri1, Jacob Schultz2
1Department of Pharmacy, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.
Antibiotics (Basel, Switzerland)
|July 27, 2024
概括
抗菌素耐药性是一个日益严重的全球健康危机. 本综述讨论了挑战,耐药病原体的新指导方针和新型抗菌剂,以应对后抗生素时代的威胁.
科学领域:
- 传染性疾病 传染性疾病
- 微生物学 微生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 抗菌素耐药性 (AMR) 构成了全球健康的重大威胁,需要采取紧急行动来制耐药性病原体的传播.
- 由于利率狭窄,对新型抗微生物药物开发的投资下降导致新抗生素生产减少.
- 美国疾病控制和预防中心 (CDC) 倡导抗微生物药物管理,强调报告和记录抗微生物药物使用和耐药性.
研究的目的:
- 审查抗微生物药物耐药性所带来的当前和未来的全球健康挑战.
- 讨论美国传染病学会 (IDSA) 关于治疗耐药格拉姆阴性病原体的新指南.
- 突出新批准或预期的抗微生物剂,它们的向病原体和临床应用.
主要方法:
- 关于与抗微生物药物耐药性相关的全球卫生挑战的文献综述.
- 美国传染病学会 (IDSA) 对抗性格拉姆阴性病原体的新指导方针的分析.
- 检查新的抗微生物药物,包括即将获得FDA批准的抗微生物药物,其覆盖范围和潜在的临床实用性.
主要成果:
- 抗菌素耐药性带来了复杂的全球健康挑战,需要多方面的解决方案.
- 新的指导方针和新兴的抗微生物药物提供了潜在的策略来对抗耐药性格拉姆阴性病原体.
- 解决抗微生物药物发现中的经济因素和改善医疗保健报销至关重要.
结论:
- 需要采取紧急行动,改善抗微生物药物发现和医疗保健补偿,以避免出现后抗生素时代.
- 讨论的指导方针和新药代表了对抗性感染管理的关键进展.
- 有效的抗微生物药物管理和新治疗方法的开发对于全球卫生安全至关重要.
相关概念视频
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Defense Against Bacterial Pathogens
1.4K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.4K
Desensitization and Tachyphylaxis
1.6K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
1.6K
Drug-Receptor Interaction: Antagonist
2.8K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
Antagonists can be classified as competitive or noncompetitive based on their...
2.8K
Spare Receptors
3.5K
Some receptors remain unoccupied even when an agonist produces a maximal response. Such empty ones are called spare receptors. In presence of spare receptors the maximum effect of an agonist drug is achieved with fewer than 100% of the receptors being occupied. To determine the presence of spare receptors, scientists often compare the concentration of the drug needed to produce 50% of the maximum effect (EC50) with the concentration of the drug needed to occupy 50% of the receptors (Kd). If the...
3.5K
Combined Effects of Drugs: Antagonism
8.4K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
8.4K


